CLINICAL_TRIALS
trial_result
· 2015-08-25
Clinical Trial Update: Multiple Dose BE Study With Nevirapine 400mg PR Tablets [Phase 1]
Summary
Phase 1 multiple-dose bioequivalence study of Nevirapine 400 mg prolonged-release tablets in HIV infection has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ratiopharm GmbH | Conditions: HIV-1 | Phase 1 | Status: COMPLETED